Drug Name: Mounjaro
Active Ingredient: tirzepatide
Indications: To improve blood sugar control in diabetes, in addition to diet and exercise
Approval Date: 5/13/2022
Company: Eli Lilly and Company
Learn more: https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-mounjaro